GGrantIndex
Sort

64,565 grants matching drug discovery

Training Grant on Alzheimer's Disease and ADRD at Indiana University

$494,484
Gary E. Landreth · Indiana University Indianapolis · T32 · FY2022 · AG

Antibiotic Drug Discovery

$494,456
Toni B. Kline · University Of Washington · U54 · FY2010 · AI

Interference with Androgen Receptor and Its Ligands

$494,453
James L Mohler · Univ Of North Carolina Chapel Hill · P01 · FY2012 · CA

Drifting to victory: resolving the paradox of M. tuberculosis evolution

$494,414
Caitlin S Pepperell · University Of Wisconsin-Madison · R01 · FY2020 · AI

Harnessing E3 Ligases for Cancer Therapy

$494,377
Daniel Nomura · University Of California Berkeley · R01 · FY2020 · CA

Structure-based Drug Discovery for the GLP-1 Receptor

$494,338
Bingfa Sun · Confometrx, Inc. · R44 · FY2017 · DK

Protease Activated Receptor Type 2 Targeting for Migraine Pain

$494,334
Theodore J Price · University Of Texas Dallas · R01 · FY2017 · NS

ITR: An Active, Personalized, Adaptive, Multi-format Biological Information Delivery System

$494,297
Snehasis Mukhopadhyay · Indiana University · · FY2000 · CSE

Blood vessel assembly from multipotent hemangioma-derived stem cells

$494,240
Joyce E. Bischoff · Boston Children'S Hospital · R01 · FY2022 · HL

Blood vessel assembly from multipotent hemangioma-derived stem cells

$494,240
Joyce E. Bischoff · Boston Children'S Hospital · R01 · FY2023 · HL

Glucose Transporter Regulation in Obesity and Diabetes

$494,237
Barbara B Kahn · Beth Israel Deaconess Medical Center · R01 · FY2020 · DK

Glucose Transporter Regulation in Obesity and Diabetes

$494,237
Barbara B Kahn · Beth Israel Deaconess Medical Center · R01 · FY2019 · DK

Functional analysis of novel testis-expressed secreted and transmembrane proteins

$494,232
Martin M Matzuk · Baylor College Of Medicine · R01 · FY2023 · HD

Measure the metabolic and genetic factors that determine M. Tuberculosis

$494,198
David Branch Moody · Brigham And Women'S Hospital · U19 · FY2020 · AI

Design, Syntheses and Studies of Novel Antituberculosis Agents

$494,149
Marvin J Miller · University Of Notre Dame · R37 · FY2016 · AI

Novel Therapeutic Agents for ALS

$494,142
Donald R. Kirsch · Cambria Biosciences, Llc · R43 · FY2007 · NS

A novel molecular diagnostic approach to classify lung cancers and predict respon

$494,130
Bruce J Mayer · University Of Connecticut Sch Of Med/Dnt · RC1 · FY2009 · CA

AO-based High Resolution Retinal Imager for Rodent Eye

$494,121
R Daniel Ferguson · Physical Sciences, Inc · R44 · FY2017 · EY

Cross-CFDE semantic and spatial interoperability for anatomy

$494,117
Peter John Hunter · University Of Auckland · OT2 · FY2020 · OD

Revolutionizing preclinical detection of risk factors for idiosyncratic drug-indu

$494,097
David W. Threadgill · North Carolina State University Raleigh · RC1 · FY2010 · DK

Photochemical synthesis of bioactive molecules

$494,071
Corey Stephenson · University Of Michigan At Ann Arbor · R01 · FY2019 · GM

Core F: Neuroimaging Core

$494,007
Howard J Rosen · University Of California, San Francisco · P30 · FY2022 · AG

Transport across two membranes by AcrAB-TolC

$493,895
Helen I. Zgurskaya · University Of Oklahoma · R01 · FY2024 · AI

High-throughput screening for NAD+-replenishing neuroprotective compounds

$493,891
Corinne Ida Lasmezas · Scripps Florida · R01 · FY2016 · NS

Transport across two membranes by AcrAB-TolC

$493,885
Helen I. Zgurskaya · University Of Oklahoma · R01 · FY2023 · AI